Fulcrum Therapeutics, Inc. (FULC) Insider Trading

Name: Fulcrum Therapeutics, Inc. (FULC) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 21, 2026): Kevin Tang (10% Owner): Purchase of 116,671 shares, $415.3K.

Get alerted when insiders trade FULC

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta